Epidermal Growth Factor Receptor (EGFR)–Retargeted Measles Virus Strains Effectively Target EGFR- or EGFRvIII Expressing Gliomas
Open Access
- 1 April 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (4) , 677-686
- https://doi.org/10.1038/sj.mt.6300105
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- CD46 Represents a Target for Adenoviral Gene Therapy of Malignant GliomaHuman Gene Therapy, 2006
- Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibodyGene Therapy, 2005
- Rescue and propagation of fully retargeted oncolytic measles virusesNature Biotechnology, 2005
- Antibody-targeted cell fusionNature Biotechnology, 2004
- Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural ModelJournal of Virology, 2004
- Epidermal Growth Factor Receptor Targeting of Replication Competent Adenovirus Enhances Cytotoxicity in Bladder CancerJournal of Urology, 2002
- Roles of Macrophages in Measles Virus Infection of Genetically Modified MiceJournal of Virology, 2001
- A Mouse Model for Glioma: Biology, Pathology, and Therapeutic OpportunitiesToxicologic Pathology, 2000
- Immunohistochemical Localization of the Epidermal Growth Factor-Receptor in Rhesus-monkey ProstateAnatomia, Histologia, Embryologia, 1996
- Localization of immunoreactive epidermal growth factor receptors in human nervous system.Journal of Histochemistry & Cytochemistry, 1988